Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +0.60% rose 5.95% to $137.91 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.10% rising 3.82% to 11,805.00 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.17% rising 1.47% to 32,196.66. This was the stock's second consecutive day of gains. Moderna Inc. closed $359.58 short of its 52-week high ($497.49), which the company achieved on August 10th.
The stock outperformed some of its competitors Friday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +1.38% fell 0.51% to $153.50, Amgen Inc. /zigman2/quotes/209157011/composite AMGN -0.03% fell 0.54% to $243.40, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN -0.06% rose 2.75% to $63.14. Trading volume (6.4 M) remained 728,357 below its 50-day average volume of 7.2 M.